
BioNano Genomics BNGO
$ 1.16
0.87%
Annual report 2025
added 03-23-2026
BioNano Genomics P/CF Ratio 2011-2026 | BNGO
Annual P/CF Ratio BioNano Genomics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.486 | -0.0515 | -0.00545 | -0.297 | -8.54 | -38.3 | -1.26 | -2.01 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.00545 | -38.3 | -6.37 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
28.3 | $ 110.24 | -2.86 % | $ 33.5 B | ||
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Waters Corporation
WAT
|
30.1 | $ 289.16 | -3.79 % | $ 17.2 B | ||
|
Exagen
XGN
|
-5.14 | $ 2.68 | -3.94 % | $ 57.8 M | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 16.36 | -11.57 % | $ 176 M | ||
|
Sotera Health Company
SHC
|
16.6 | $ 13.13 | -3.03 % | $ 3.73 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
17.7 | $ 62.25 | -5.81 % | $ 24.3 B | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 23.53 | -4.74 % | $ 654 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 159.16 | -3.62 % | $ 7.89 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 195.51 | -1.33 % | $ 21.7 B | ||
|
Organovo Holdings
ONVO
|
-0.328 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
-1.87 | - | -16.95 % | $ 1.54 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
PerkinElmer
PKI
|
22.5 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
0.888 | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 8.7 | -4.92 % | $ 1.89 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 264.2 | -1.56 % | $ 22 B | ||
|
Psychemedics Corporation
PMD
|
-11.4 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
-2.44 | $ 25.97 | -4.52 % | $ 33.7 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 16.78 | -3.95 % | $ 894 M | ||
|
Quotient Limited
QTNT
|
-2.36 | - | -11.32 % | $ 1.1 M | ||
|
Syneos Health
SYNH
|
20.8 | - | - | $ 4.46 B | ||
|
Renalytix AI plc
RNLX
|
-0.754 | - | 5.66 % | $ 22.7 M | ||
|
VolitionRx Limited
VNRX
|
-2.12 | $ 0.2 | 1.87 % | $ 19.2 M | ||
|
Bioventus
BVS
|
8.14 | $ 8.94 | -3.46 % | $ 596 M | ||
|
Co-Diagnostics
CODX
|
-1.58 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Meridian Bioscience
VIVO
|
16.4 | - | - | $ 1.49 B | ||
|
Danaher Corporation
DHR
|
23.3 | $ 181.52 | -3.27 % | $ 129 B | ||
|
Surmodics
SRDX
|
2.23 K | - | - | $ 608 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.297 | $ 4.29 | -6.54 % | $ 2.3 M |